Galectin Therapeutics (GALT) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.90% |
| Dec 31, 2025 | 32.36% |
| Sep 30, 2025 | -8.43% |
| Jun 30, 2025 | 21.04% |
| Mar 31, 2025 | 20.16% |
| Dec 31, 2024 | -7.05% |
| Sep 30, 2024 | 9.63% |
| Jun 30, 2024 | -8.16% |
| Mar 31, 2024 | -14.28% |
| Dec 31, 2023 | 28.35% |
| Sep 30, 2023 | -53.00% |
| Jun 30, 2023 | 20.39% |
| Mar 31, 2023 | -7.74% |
| Dec 31, 2022 | -24.68% |
| Sep 30, 2022 | 11.33% |
| Jun 30, 2022 | 2.41% |
| Mar 31, 2022 | -36.06% |
| Dec 31, 2021 | 14.83% |
| Sep 30, 2021 | -0.51% |
| Jun 30, 2021 | -34.29% |
| Mar 31, 2021 | 19.92% |
| Dec 31, 2020 | -32.95% |
| Sep 30, 2020 | 3.64% |
| Jun 30, 2020 | -74.08% |
| Mar 31, 2020 | 31.76% |
| Dec 31, 2019 | -84.53% |
| Sep 30, 2019 | 8.03% |
| Jun 30, 2019 | 66.29% |
| Mar 31, 2019 | -171.51% |
| Dec 31, 2018 | -9.95% |
| Sep 30, 2018 | 25.85% |
| Jun 30, 2018 | 9.58% |
| Mar 31, 2018 | -63.01% |
| Dec 31, 2017 | 40.22% |
| Sep 30, 2017 | 3.06% |
| Jun 30, 2017 | 7.68% |
| Mar 31, 2017 | -7.05% |
| Dec 31, 2016 | -4.76% |
| Sep 30, 2016 | 20.28% |
| Jun 30, 2016 | 16.88% |
| Mar 31, 2016 | -41.13% |
| Dec 31, 2015 | 19.26% |
| Sep 30, 2015 | -24.76% |
| Jun 30, 2015 | 2.82% |
| Mar 31, 2015 | -27.87% |
| Dec 31, 2014 | -2.98% |
| Sep 30, 2014 | -3.27% |
| Jun 30, 2014 | 31.01% |
| Mar 31, 2014 | -73.83% |
| Dec 31, 2013 | 16.44% |
| Sep 30, 2013 | 68.02% |
| Jun 30, 2013 | -235.28% |
| Mar 31, 2013 | -28.21% |
| Dec 31, 2012 | 9.28% |
| Sep 30, 2012 | -0.03% |
| Jun 30, 2012 | -35.39% |
| Mar 31, 2012 | 40.72% |
| Dec 31, 2011 | -58.96% |
| Sep 30, 2011 | 40.54% |
| Jun 30, 2011 | -44.53% |
| Mar 31, 2011 | -79.31% |
| Dec 31, 2010 | 20.06% |
| Sep 30, 2010 | 23.27% |